Moderated, page-1308

@Barman76

hahahahahahahah schooled, no answers, EVER possible, all fluff with no real knowledge.
Came out of your back pocket this one?

1. How about tell me about the number of cells needed for treatment?

2. Tell me about number of infusions needed.

3. Tell me about the TR in 5 of 9 Grade 3 patients

4. Tell me about COGS (if you can work out 1 and 2 first)

5. Tell me about if Adults (who have many other complications/ age) vs Children, and what cohort is easier to treat. (think about Covid ARDs and immune systems)

6. Tell me about 3D

Highly unlikely you'll get past 1. BUT if you do manage to answer 1 and 2 - finally, Tell me about Potency.

Because there is already large and mounting evidence (Cell used in CYP GvHD trial for one) that IPSC derived MSCs are more potent and BM Harvested/ Derived.....over to you now.